GENE ONLINE|News &
Minerva Neurosciences Appoints Dr. Sheila O’Connor as President and CEO Following Leadership Transition
Minerva Neurosciences, Inc. has announced a leadership transition, with Dr. Remy Luthringer stepping down from his role as Executive Chairman and Chief Executive Officer. The company confirmed that Dr. Luthringer will remain involved as a member of the Board of Directors. Concurrently, Minerva named Dr. Sheila O’Connor as its new President and CEO, effective immediately.
Dr. O’Connor brings over 20 years of experience in the biopharmaceutical industry to her new role at Minerva. Prior to this appointment, she held various leadership positions at multiple healthcare organizations, focusing on drug development and commercialization strategies. The company stated that this leadership change aligns with its ongoing efforts to advance its clinical programs and strategic priorities in neuroscience research and development.
Newsflash | Powered by GeneOnline AI
Source: GO-AI-ne1
For any suggestion and feedback, please contact us.
Date: April 2, 2026
©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
LATEST
Study Finds Non-Communicable Diseases Consume Large Portion of Household Income Among Elderly in India
2026-04-19
Study Identifies Antiviral Compounds in Egyptian Ziziphus spina-christi Effective Against Respiratory Viruses
2026-04-19
Elevated Fetal Catecholamine Metabolites Linked to Growth Restriction in Sheep Model Study
2026-04-18
EVENT
2026-04-17
AACR Annual Meeting 2026 (Cancer Research & Early-Stage Breakthroughs)
San Diego, California
